India’s Bioeconomy 2025 में $195 bn तक बढ़ी – 17‑18% YoY Growth, BioE3 Policy & RDI Fund बायोटेक को तेज़ करता है
Union Minister of State for Science & Technology <strong>Dr Jitendra Singh</strong> ने घोषणा की कि India’s <span class="key-term" data-definition="Bioeconomy – economic activities that use biological resources, processes and principles to produce goods and services; a focus area for GS3 (Economy) and GS1 (Science & Technology) in UPSC.">Bioeconomy</span> $10 bn (2014) से बढ़कर $195 bn (2025) हो गई, जो 17‑18% YoY की दर से बढ़ रही है। सरकार ने <span class="key-term" data-definition="BioE3 Policy – ‘Biotechnology for Economy, Environment and Employment’; a policy framework to promote bio‑based industries and sustainable manufacturing (GS3).">BioE3 Policy</span> और ₹1 lakh‑crore <span class="key-term" data-definition="RDI Fund – Research, Development and Innovation Fund aimed at channeling long‑term investment into biotech scale‑up projects (GS3).">RDI Fund</span> को प्रमुख सक्षमकर्ता के रूप में उजागर किया, जिसमें 11,800 से अधिक biotech startups इस क्षेत्र की वृद्धि को चला रहे हैं।
India’s Bioeconomy Expands Rapidly – Key Policy Pushes Highlighted Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh , announced that the nation’s Bioeconomy has risen from about USD 10 billion in 2014 to **USD 195 billion in 2025**, registering a **17‑18% annual growth** in the last year. The sector now contributes **≈4.8% to India’s GDP** and positions the country as a global biotechnology hub. Key Developments India aims for a USD 300 billion bioeconomy by 2030 , driven by a strong base of scientists, entrepreneurs and more than 11,800 biotech startups . Launch of the BioE3 Policy , targeting precision biotherapeutics, smart proteins, climate‑resilient agriculture, bio‑based chemicals and carbon‑capture technologies. Establishment of shared infrastructure such as bio‑foundries, Bio‑AI hubs and advanced biomanufacturing platforms under BIRAC’s guidance. Announcement of a ₹1 lakh‑crore RDI Fund , with BIRAC as the nodal agency for funding scale‑up and technology translation. Important Facts Annual growth rate of **17‑18%** in 2025, up from **USD 165 billion** in 2024. Compound Annual Growth Rate ( CAGR ) of **≈18%** since 2020. India’s bioeconomy now accounts for **nearly 5% of national GDP**. Release of the India Bioeconomy Report (IBER) 2026 and the BIRAC Impact Report , documenting commercialization, job creation and societal impact. Focus on nurturing talent from tier‑2 and tier‑3 cities, and promoting women entrepreneurs. UPSC Relevance The rapid expansion of the bioeconomy touches multiple UPSC syllabus areas: GS III – Economy (sectoral contribution to GDP, investment flows), GS I – Science & Technology (biotech innovation
Quick Reference
Key Insight
BioE3 Policy and ₹1 lakh‑crore RDI Fund propel India's bioeconomy towards $300 bn by 2030.
Key Facts
- India's bioeconomy grew from $10 bn (2014) to $195 bn in 2025, a 17‑18% YoY increase.
- The sector now contributes about 4.8% to India's GDP (≈5%).
- Target: $300 bn bioeconomy by 2030, driven by ~11,800 biotech startups.
- Government launched the BioE3 Policy (Biotechnology for Economy, Environment & Employment) to boost precision biotherapeutics, smart proteins, climate‑resilient agriculture, bio‑based chemicals and carbon‑capture.
- ₹1 lakh‑crore (₹100,000 crore) Research, Development & Innovation (RDI) Fund announced, with BIRAC as nodal agency for scale‑up funding.
- Shared infrastructure such as bio‑foundries, Bio‑AI hubs and advanced biomanufacturing platforms set up under BIRAC.
- India Bioeconomy Report (IBER) 2026 and BIRAC Impact Report released, highlighting commercialization, job creation and societal impact.
Background
The rapid expansion of India's bioeconomy aligns with GS III (Economy) and GS I (Science & Technology) themes, reflecting a strategic push to diversify the industrial base, generate high‑skill employment, and meet climate goals through bio‑based solutions. Policy instruments like BioE3 and the RDI Fund aim to bridge the gap between research and commercial scale, positioning India as a global biotech hub.
UPSC Syllabus
- Essay — Economy, Development and Inequality
- GS3 — Developments in science and technology and their applications
- Essay — Science, Technology and Society
- GS3 — Indian Economy - Planning, mobilization of resources, growth, development and employment
- GS2 — Government policies and interventions for development
Mains Angle
In Mains, this can be addressed in GS III (Economy) or GS I (Science & Technology) by evaluating how targeted biotech policies and large‑scale funding can drive inclusive growth, innovation ecosystems, and sustainable development.